These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 25040034)

  • 1. The basal insulin dose; a lesson from prolonged fasting in young individuals with type 1 diabetes.
    Strich D; Teomim R; Gillis D
    Pediatr Diabetes; 2015 Dec; 16(8):629-33. PubMed ID: 25040034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Reducing Basal Insulin During Ramadan Fasting by Children and Adolescents with Type 1 Diabetes Decrease the Risk of Symptomatic Hypoglycemia?
    Deeb A; Al Qahtani N; Attia S; Al Suwaidi H; Nagelkerke N
    Diabetes Technol Ther; 2016 Sep; 18(9):539-42. PubMed ID: 27500913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 diabetes and prolonged fasting.
    Reiter J; Wexler ID; Shehadeh N; Tzur A; Zangen D
    Diabet Med; 2007 Apr; 24(4):436-9. PubMed ID: 17367310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.
    Davis SN; Horton ES; Battelino T; Rubin RR; Schulman KA; Tamborlane WV
    Diabetes Technol Ther; 2010 Apr; 12(4):249-55. PubMed ID: 20210562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes.
    Vigeral C; Sola-Gazagnes A; Nejjar S; M'Bemba J; Boitard C; Slama G; Elgrably F; Larger E
    Diabetes Metab; 2011 Dec; 37(6):553-9. PubMed ID: 21802332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
    Patton SR; Dolan LM; Henry R; Powers SW
    Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report.
    Benbarka MM; Khalil AB; Beshyah SA; Marjei S; Awad SA
    Diabetes Technol Ther; 2010 Apr; 12(4):287-90. PubMed ID: 20210567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
    Rosenlund S; Theilade S; Hansen TW; Andersen S; Rossing P
    Acta Diabetol; 2014 Dec; 51(6):955-62. PubMed ID: 25274393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
    Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Szypowska A; Lipka M; Błazik M; Golicka D; Groele L; Pańkowska E
    Acta Paediatr; 2009 Mar; 98(3):523-6. PubMed ID: 19046348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era.
    Bolli GB; Andreoli AM; Lucidi P
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S43-52. PubMed ID: 21668336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    ; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
    Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
    Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.